Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001250853-14-000142

Options or other derivatives

  • Chief Financial Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Handelman Michael D · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-12-05 Grant or award : show line 1 in the form Stock Option (right to buy) +40,000 $6.25 2024-12-04 40,000 40,000 D
Loading xslF345X03/primary_doc.xml…